Associations of medical outcomes with substances involved in suicide attempt cases age 50 and older reported to U.S. Poison Centers, 2016–2023
Background and aimsAfter a slight decline in suicide rates during the COVID-19 pandemic, suicide rates and suicide attempts in the U.S. have been increasing again in 2022 and 2023. Compared to younger age groups, the 50+ age group has significantly higher rates of serious medical outcomes from suici...
Saved in:
| Main Authors: | Namkee G. Choi, Bryan Y. Choi, C. Nathan Marti, S. David Baker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1505040/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benzodiazepine Adverse Reaction Cases Age 50 and Older Reported to the U.S. Poison Centers: Healthcare Use and Major Medical Effects
by: Bryan Y. Choi, et al.
Published: (2024-08-01) -
Psychological assessment of persons following suicide attempt by self-poisoning
by: Dedić Gordana, et al.
Published: (2010-01-01) -
Management of suicide attempts
by: L. Koen
Published: (2004-09-01) -
Age-Dependent Analysis of Suicidal Ideation, Suicide Attempts, and Suicides Associated with SSRI and SNRI Drugs Based on Pharmacovigilance Data
by: Daria Schetz, et al.
Published: (2024-12-01) -
Medical Discourse on Suicide in Post-War Britain - To Decriminalize Suicide and Attempted Suicide -
by: Hye Jean HWANG
Published: (2024-12-01)